Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Erythromycin ethyl succinate 250mg/5ml susp sugar free
0501050H0AAAMAM
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 14,389 |
|
Erythromycin ethyl succinate 250mg/5ml oral suspension
0501050H0AAABAB
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 14,353 |
|
Erythromycin ethyl succinate 125mg/5ml susp sugar free
0501050H0AAALAL
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 8,018 |
|
Erythromycin ethyl succinate 125mg/5ml oral suspension
0501050H0AAAAAA
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 7,082 |
|
Erythromycin ethyl succinate 500mg tablets
0501050H0AAAEAE
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 2,934 |
|
Erythromycin ethyl succinate 500mg/5ml oral suspension
0501050H0AAACAC
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 738 |
|
Erythromycin ethyl succinate 500mg/5ml susp sugar free
0501050H0AAANAN
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 318 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.